Hypofractionated Stereotactic Radiotherapy | List of Frontiers open access articles

Original Research

Published on 30 Mar 2021

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma

in Neuro-Oncology and Neurosurgical Oncology

Donatella Arpa
Elisabetta Parisi
Giulia Ghigi
Annalisa Cortesi
Pasquale Longobardi
Patrizia Cenni
Martina Pieri
Luca Tontini
Elisa Neri
Simona Micheletti

Frontiers in Oncology

doi 10.3389/fonc.2021.643469

5,106 views
13 citations

Original Research

Published on 04 Sep 2017

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy

in Radiation Oncology

Mira A. Patel
Ariel E. Marciscano
Chen Hu
Ignacio Jusué-Torres
Rupen Garg
Arif Rashid
Howard W. Francis
Michael Lim
Kristin J. Redmond
Daniele Rigamonti

Frontiers in Oncology

doi 10.3389/fonc.2017.00200

9,624 views
25 citations

Original Research

Published on 27 Feb 2025

Hypofractionated stereotactic radiotherapy using coplanar VMAT for single small brain metastasis: dosimetric analysis and clinical outcomes

in Radiation Oncology

Jialu Lai
An Li
Xianhu Zeng
Jia Liu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1428922

1,617 views

Original Research

Published on 27 Feb 2019

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

in Radiation Oncology

Khush S. Aujla
Alan W. Katz
Deepinder P. Singh
Paul Okunieff
Michael T. Milano

Frontiers in Oncology

doi 10.3389/fonc.2019.00111

4,364 views
10 citations

Original Research

Published on 04 Apr 2022

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis

in Neuro-Oncology and Neurosurgical Oncology

Michael Yan
Osbert Zalay
Thomas Kennedy
Timothy E. Owen
James Purzner
Shervin Taslimi
Teresa Purzner
Ryan Alkins
Nikitha Moideen
Andrea S. Fung

Frontiers in Oncology

doi 10.3389/fonc.2022.869572

5,368 views
6 citations

Case Report

Published on 09 Jul 2025

The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report

in Precision Medicine

Joaquim Bosch-Barrera
Elia Sais
Eduard Teixidor-Vilà
Carmen Vásquez-Dongo
Alejandro Hernandez-Martínez
Alvaro Romera
Mel.lina Pinsach-Abuin
Bernat del Olmo
Glòria Oliveras
Emma Polonio-Alcalá

Frontiers in Medicine

doi 10.3389/fmed.2025.1612327

3,425 views
1 citation

Original Research

Published on 08 Dec 2020

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation

in Radiation Oncology

I. Frank Ciernik
Yann Gager
Christof Renner
Sybille Spieker
Nicole Arndt
Karsten Neumann

Frontiers in Oncology

doi 10.3389/fonc.2020.577443

4,335 views
5 citations

Original Research

Published on 30 May 2025

Dosimetric advantages of dual-layer MLC in hypofractionated stereotactic radiotherapy for multiple brain metastases: a comparative study with single-layer MLC

in Radiation Oncology

Changyou Zhong
Suyan Bi
Haidong Yu
Zhendong Jiang
Zhitao Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1564801

2,188 views
1 citation

Articles

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy

Hypofractionated stereotactic radiotherapy using coplanar VMAT for single small brain metastasis: dosimetric analysis and clinical outcomes

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis

The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation

Dosimetric advantages of dual-layer MLC in hypofractionated stereotactic radiotherapy for multiple brain metastases: a comparative study with single-layer MLC